Last reviewed · How we verify

NCT06302920

Effect of Kinesiotaping on Pain,Edema and Kinesiophobia in Patients With Complex Regional Pain Syndrome

Status unknown NA Last updated 12 March 2024
What this trial tests

NA trial testing Kinesiotape in Complex Regional Pain Syndrome Type I in 60 participants. Status unknown.

Timeline
20 May 2024
Primary endpoint
20 June 2024
20 December 2024

Quick facts

Lead sponsorAlanya Alaaddin Keykubat University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date20 May 2024
Primary completion20 June 2024
Estimated completion20 December 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Alanya Alaaddin Keykubat University

Who can join

Adults 18 to 80, any sex, with Complex Regional Pain Syndrome Type I. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients will be divided into 2 groups according to the random numbers table, and both groups will receive a conventional physical therapy and rehabilitation program and nutritional support. Afterwards, edema-reducing kinesiotaping will be applied to one group. The applied kinesio tape will remain on the patient for 5 days and will be taped again after 2 days without tape. In this way, taping will be done 3 times in total, once a week for 3 weeks. During this period, patients will continue their routine physical therapy program and measurements will be taken by the same researcher in the 1st week of treatment and 3 weeks later.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Kinesiotape

Trials testing the same drug.

Other recruiting trials for Complex Regional Pain Syndrome Type I

Currently open trials in the same condition.

Other Alanya Alaaddin Keykubat University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06302920.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing